for either the test or reference product? [Outliers]

posted by mittyri – Russia, 2019-02-05 15:58 (803 d 19:07 ago) – Posting: # 19871
Views: 4,818

Hi Helmut,

maybe I'm only one who is confused with that statement, but:
3. The subject in question should be identified as an outlier for all parameters, for either the test or reference product, upon which the bioequivalence decision is to be based.

Either? Sorry for my poor grammar knowledge but 'either' is a kind of choice, right? So does it mean we need to find out the outliers using the datasets splitted by formulation, not for the ratio T/R? :confused:

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 4 (0 registered, 4 guests [including 1 identified bots]).
Forum time: Monday 12:06 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5